Created at	Source	Raw Value	Validated value
March 20, 2021, 12:31 a.m.	usa	Determine the safety of KDS-1000 given at low and high doses compared to placebo by collecting the rate and severity of adverse events (AE)	Determine the safety of KDS-1000 given at low and high doses compared to placebo by collecting the rate and severity of adverse events (AE)
March 17, 2021, 12:31 a.m.	usa	Determine the safety of KDS-1000 given at low and high doses compared to placebo	Determine the safety of KDS-1000 given at low and high doses compared to placebo